The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
PSTV · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | PSTV | CLSDQ | PRCT | ANGO |
|---|---|---|---|---|
| Moat Score (0–100) | 40 (highest) | 40 (highest) | 40 (highest) | 40 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 46 | 25 | 65 (highest) | 31 |
| Pricing power | 42 | 95 (highest) | 56 | 89 |
| Returns on capital | — | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 28 | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital allocation | 44 (highest) | 24 | 24 | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $386M | $19.1M | $1.3B | $625M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2024 | FY2025 | FY2026 |